Immunology & Immunogenetics

Cancer Immunology

Cancer Immunology is focused on three major areas,  the basic mechanisms of cancer immunity, engineering immune-based therapies, and developing clinical trials to study these new therapies. Cancer Immunology & Immunotherapy (CII) has reported significant advances in the field of tumor immunology.  There are  new concepts and advances in basic, translational, and clinical cancer immunology and immunotherapy. Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells.  Based on new research that has revealed genetic links to immune behaviour, they are now combining these vaccines with other treatments, including targeted therapies, bone marrow transplant. Immunology advances also have improved bone marrow transplant outcomes by preventing the patient’s immune system from rejecting donor marrow. Cancer immunotherapy is the use of the immune system to treat cancer. Immunotherapies can be categorized as active, passive or hybrid. Active immunotherapy directs the immune system to attack tumour cells by targeting tumour-associated antigens (TAAs). Passive immunotherapies enhance existing anti-tumour responses and include the use of monoclonal antibodies, lymphocytes and cytokines